PMID: 9192246May 1, 1997Paper

Disappearance of the 'no-reflow' phenomenon after adjunctive intracoronary administration of nicorandil in a patient with acute myocardial infarction

Japanese Circulation Journal
Y SakataA Hirayama

Abstract

Adjunctive intracoronary administration of nicorandil, an ATP-sensitive potassium channel opener, after successful coronary revascularization was performed in a 54-year-old patient with acute myocardial infarction. The 'no-reflow' phenomenon disappeared after nicorandil administration and significant functional recovery of the infarcted myocardium was achieved. This suggests that nicorandil could eliminate the 'no-reflow' phenomenon after successful coronary revascularization.

References

Jun 20, 1989·The American Journal of Cardiology·N Taira
Dec 1, 1974·The Journal of Clinical Investigation·R A KlonerR B Jennings

❮ Previous
Next ❯

Citations

May 26, 2005·Current Treatment Options in Cardiovascular Medicine·Shereif H Rezkalla, Robert A Kloner
Jul 24, 2002·Circulation Journal : Official Journal of the Japanese Circulation Society·Jun-ichi KotaniSeiki Nagata
Oct 2, 2004·Circulation Journal : Official Journal of the Japanese Circulation Society·Sang Yup LimJung Chaee Kang
Aug 29, 2006·Circulation Journal : Official Journal of the Japanese Circulation Society·Satoshi OtaTakeshi Nakano
Feb 6, 2002·Circulation·Shereif H Rezkalla, Robert A Kloner
Oct 13, 2006·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Raymond I HuangMichael P Savage

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.